Medical Marijuana

May 2018

Women’s Health

The American health care system frequently fails to address patient’s specific health care needs. As an organization committed to the advancement of world class medical research at the  Hadassah Medical Organization (HMO) in Israel, Hadassah, the Women’s Zionist Organization  of America, Inc. stands with doctors and patients calling for the federal legalization of medical  marijuana.

HMO is at the forefront of groundbreaking cannabis research, as one of its physicians, Dr.  Raphael Mechoulam pioneered the re-isolation of cannabidiol (CBD), a major nonpsychoactive  compound in cannabis. It has been used in Israel to treat epilepsy, inflammation, rheumatoid  arthritis symptoms, and sugar levels for Diabetes I patients.

More than 20 years have passed since California became the first state to legalize medical  marijuana. What has followed is a domino effect of states legalizing medical marijuana based on  California as a case study that cannabis can provide relief for a variety of conditions. As of April  2017, 29 states have legalized marijuana in some form, bringing patients relief and expanding the  authorization of choices in treatment they receive, based on the doctor-patient relationship.

Yet, a complete understanding of the benefits of medical marijuana are severely limited as the  cannabis plant and its products are designated as a Schedule I drug, preventing any large-scale  research on patients. Thorough research to understand proper usage and potential benefits of  medical marijuana for patients is critical to federal legalization of cannabis. Today, many  Americans support legalization of medical marijuana.

Therefore, Hadassah calls for:

  • federal legalization of medical marijuana, so that patients in every state may benefit from medical marijuana
  • reframing of medical marijuana policy as a doctor-patient decision; and
  • research to fully investigate the potential benefits of medical marijuana.

Hadassah's Policy Statements represent the organization's official stance on a wide variety of issues facing our nation, Israel and other international matters of concern. Policy Statements are debated and voted on at national meetings by Hadassah’s national board and delegates from our membership. Once approved, statements become official policies of the organization and serve to define Hadassah's overall agenda and advocacy priorities. Hadassah, as a charitable organization classified under section 501(c)(3) of the Internal Revenue Code, is prohibited from any direct or indirect support of, or opposition to, candidates for public office.